IMCL
IMCL Articles
Carl Icahn appears to have won a blue ribbon for ImClone Systems (NASDAQ: IMCL) shareholders. The biotech stock is trading up on a very weak trading day after what many had deemed as a fishy merger...
Published:
Last Updated:
According to Reuters, the economic bailout bill passed the Senate and is likely to pass the House. Reuters reports that GE (GE) raised $15 billion with some of the capital coming from Warren Buffett....
Published:
Last Updated:
According to Reuters, Congress is ready to vote on a $700 billion financial bailout package. Reuters reports that Belgian-Dutch group Fortis was nationalized Reuters reports that British mortgage...
Published:
Last Updated:
ImClone Systems Inc. (NASDAQ: IMCL) is among the biotech bonanza merger candidates with one deal on the table and perhaps an unofficial deal waiting in the wings. Bristol-Myers Squibb Co. (NYSE:...
Published:
Last Updated:
Bristol-Myers Squibb (NYSE: BMY) has sent a letter to Imclone Systems (NASDAQ: IMCL) in response to yesterday’s rejection of its buyout offer. It said it is disappointed that the $60.00 bid was...
Published:
According to Reuters, Washington Mutual (WM) fell 30% to a 17-year low. Reuters reports that billionaire Carlos Slim has bought 6% of The New York Times (NYT). Reuters writes that Northrop Grumman...
Published:
Last Updated:
ImClone Systems Inc. (NASDAQ: IMCL) is a biotech buyout bonanza stock that traders and investors have been watching closely. The company has said that the proposed $60.00 per share cash buyout from...
Published:
According to Reuters, large Yahoo! (YHOO) holder Capital Research want to know whether vote counts from the company’s annula meeting were accurate. Reuters writes that the Fed is seen as holding...
Published:
Last Updated:
Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY) regarding the cash buyout of the company. The...
Published:
Last Updated:
These are some of the key downgrades or negative calls we are seeing from analysts this Friday morning with more than two hours to the open: First Mercury (FMR) Cut to Neutral at JPMorgan. GOL Linhas...
Published:
Another biotech giant is biting the dust via a buyout offer. ImClone Systems Inc. (NASDAQ: IMCL) has been given a buyout offer from Bristol-Myers (NYSE: BMY) at $60.00 per share. As per the filing:...
Published:
ImClone Systems Incorporated (NASDAQ: IMCL) has just announced that ERBITUX(R) has received marketing authorization in Japan for use in treating patients with advanced or metastatic colorectal cancer...
Published:
Carl Icahn is a billionaire financier, activist, and investor. Most think of Icahn as an activist investor that wants to get inside and drive value without having to acquire the whole company to...
Published:
Last Updated:
AMAG Pharmaceuticals (NASDAQ: AMAG) has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI) beginning May 19, 2008. AMAG shares up $1.26 at $39.85. The 52-week range is $38.16 to $72.95. Cell...
Published:
These are ten of the top analyst calls we are seeing this Monday morning: American International Group (NYSE: AIG) Cut to Neutral from Buy at Goldman Sachs. Build-A-Bear Workshop (NYSE: BBW) Cut to...
Published: